scholarly journals Transfusion-transmitted hepatitis E in Germany, 2013

2014 ◽  
Vol 19 (21) ◽  
Author(s):  
D Huzly ◽  
M Umhau ◽  
D Bettinger ◽  
T Cathomen ◽  
F Emmerich ◽  
...  

The reported IgG seroprevalence against hepatitis E virus (HEV) in German blood donations is 6.8%, and HEV RNA detected in 0.08%, but documented evidence for HEV transmission is lacking. We identified two donations from a single donor containing 120 IU HEV RNA/mL plasma and 490 IU/mL. An infectious dose of 7,056 IU HEV RNA was transmitted via apheresis platelets to an immunosuppressed patient who developed chronic HEV. Further, transmission was probable in an immunocompetent child.

Viruses ◽  
2020 ◽  
Vol 12 (2) ◽  
pp. 139 ◽  
Author(s):  
Nicolas Capelli ◽  
Martine Dubois ◽  
Mélanie Pucelle ◽  
Isabelle Da Silva ◽  
Sébastien Lhomme ◽  
...  

Hepatitis E virus (HEV) is a major concern in public health worldwide. Infections with HEV genotypes 3, 4, or 7 can lead to chronic hepatitis while genotype 1 infections can trigger severe hepatitis in pregnant women. Infections with all genotypes can worsen chronic liver diseases. As virions are lipid-associated in blood and naked in feces, efficient methods of propagating HEV clinical strains in vitro and evaluating the infectivity of both HEV forms are needed. We evaluated the spread of clinical strains of HEV genotypes 1 (HEV1) and 3 (HEV3) by quantifying viral RNA in culture supernatants and cell lysates. Infectivity was determined by endpoint dilution and calculation of the tissue culture infectious dose 50 (TCID50). An enhanced HEV production could be obtained varying the composition of the medium, including fetal bovine serum (FBS) and dimethylsulfoxide (DMSO) content. This increased TCID50 from 10 to 100-fold and allowed us to quantify HEV1 infectivity. These optimized methods for propagating and measuring HEV infectivity could be applied to health safety processes and will be useful for testing new antiviral drugs.


Transfusion ◽  
2016 ◽  
Vol 56 (12) ◽  
pp. 3086-3093 ◽  
Author(s):  
Ashish C. Shrestha ◽  
Robert L.P. Flower ◽  
Clive R. Seed ◽  
Anthony J. Keller ◽  
Robert Harley ◽  
...  

2009 ◽  
Vol 7 (S1) ◽  
pp. S55-S63 ◽  
Author(s):  
Ronald Fayer ◽  
Palmer Orlandi ◽  
Michael L. Perdue

The hepatitis E virus and Cryptosporidium are waterborne pathogens, each consisting of distinct taxa, genotypes and isolates that infect humans, nonhuman animal species or both. Some are associated with disease, others are not. Factors contributing to disease are extremely complicated, possibly involving differences in one or more traits associated with an organism's taxon, genotype or isolate and its infectious dose, and age or condition, as well as the host's physiology and immune status. Potential virulence factors have not yet been identified for HEV. Putative virulence factors for Cryptosporidium might be found in recently recognized genes involved in processes such as excystation, adherence to host cells, invasion, intracellular maintenance and host cell destruction.


2019 ◽  
Vol 19 (1) ◽  
Author(s):  
Joachim Denner ◽  
Sven Pischke ◽  
Eike Steinmann ◽  
Johannes Blümel ◽  
Dieter Glebe

2019 ◽  
Vol 24 (10) ◽  
Author(s):  
Heli Harvala ◽  
Patricia E Hewitt ◽  
Claire Reynolds ◽  
Callum Pearson ◽  
Becky Haywood ◽  
...  

Introduction Hepatitis E virus (HEV), the most common cause of acute hepatitis in many European countries, is transmitted through consumption of processed pork but also via blood transfusion and transplantation. HEV infection can become persistent in immunocompromised individuals. Aim We aimed to determine the incidence and epidemiology of HEV infection in English blood donors since the introduction of donation screening in 2016. Methods Between March 2016 and December 2017, 1,838,747 blood donations were screened for HEV RNA. Donations containing HEV RNA were further tested for serological markers, RNA quantification and viral phylogeny. Demographics, travel and diet history were analysed for all infected donors. Results We identified 480 HEV RNA-positive blood donations during the 22-month period, most (319/480; 66%) donors were seronegative. Viral loads ranged from 1 to 3,230,000 IU/ml. All sequences belonged to genotype 3, except one which likely represents a new genotype. Most viraemic donors were over 45 years of age (279/480; 58%), donors aged between 17 and 24 years had a seven-times higher incidence of HEV infection than other donors between March and June 2016 (1:544 donations vs 1:3,830). HEV-infected blood donors were evenly distributed throughout England. Screening prevented 480 HEV RNA-positive blood donations from reaching clinical supply. Conclusion HEV screening of blood donations is a vital step in order to provide safer blood for all recipients, but especially for the immunosuppressed. The unusually high rates of HEV infection in young blood donors may provide some insight into specific risks associated with HEV infection in England.


Transfusion ◽  
2017 ◽  
Vol 57 (2) ◽  
pp. 258-266 ◽  
Author(s):  
Anneke S. de Vos ◽  
Mart P. Janssen ◽  
Hans L. Zaaijer ◽  
Boris M. Hogema

Author(s):  
Li Ping Wong ◽  
Hai Yen Lee ◽  
Chee Sieng Khor ◽  
Juraina Abdul-Jamil ◽  
Haridah Alias ◽  
...  

2011 ◽  
Vol 49 (01) ◽  
Author(s):  
C Dorloff ◽  
J Hemberger ◽  
M Odenthal ◽  
H Holzmann ◽  
S Aberle ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document